Genocea Biosciences (GNCA) Tops Q1 EPS by 7c

Genocea Biosciences (NASDAQ: GNCA) reported Q1 EPS of ($0.35), $0.07 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $235 thousand versus the consensus estimate of $60 thousand.

For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c